Taisho Pharmaceutical Co., Ltd.

Overview

Taisho Pharmaceutical Co., Ltd. is one of Japan's leading pharmaceutical companies, known for its over-the-counter (OTC) products and prescription drugs. As a public company, it focuses on developing healthcare solutions that contribute to human health and well-being.

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Taisho Pharmaceutical Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Taisho Pharmaceutical Co., Ltd. holds 0 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HYDROCORTISONE BUTEPRATEInactive1989-12-25
• CARBINOXAMINE MALEATEInactive1977-06-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Taisho Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.